Amylyx Pharmaceuticals
AMLX
#3641
Rank
ยฃ3.04 B
Marketcap
ยฃ27.29
Share price
-1.01%
Change (1 day)
302.33%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of ยฃ69.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 ยฃ69.62 M-76.71%
2023 ยฃ0.29 B1526.62%
2022 ยฃ18.37 M
2021 N/A